BCAB - CIK 0001826892
The table below shows BioAtla, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.96M | $8.32M | $18.21M | $32.36M | $56.52M | $61.66M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $3.09M |
| $9.67M |
| $20.61M |
| $37.54M |
| $60.57M |
| $66.49M |
| Property, plant & equipment | $0.00 | $324.00K | $380.00K | $495.00K | $906.00K | $1.13M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $8.57M | $15.91M | $27.13M | $38.29M | $62.24M | $68.64M |
| Accounts payable | $12.12M | $5.85M | $4.64M | $4.70M | $2.93M | $1.36M |
| Total current liabilities | $20.69M | $17.98M | $16.60M | $16.01M | $19.46M | $17.46M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $45.88M | $47.15M | $43.87M | $37.74M | $39.27M | $37.27M |
| Retained earnings | -$551.99M | -$535.86M | -$520.08M | -$501.37M | -$471.15M | -$460.57M |
| Total equity | -$37.31M | -$31.24M | -$16.75M | $547.00K | $22.97M | $31.37M |